Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Clinical significance of the cardiovascular effects of fingolimod treatment in multiple sclerosis].
The role of kinin B1 and B2 receptors in the persistent pain induced by experimental autoimmune encephalomyelitis (EAE) in mice: Evidence for the involvement of astrocytes.
Interleukin-34 restores blood-brain barrier integrity by upregulating tight junction proteins in endothelial cells.
Correction: Acute Disseminated Encephalomyelitis Onset: Evaluation Based on Vaccine Adverse Events Reporting Systems.
Colour vision impairment is associated with disease severity in multiple sclerosis.
Axon-glia interaction and membrane traffic in myelin formation.
Health related quality of life in patients recently diagnosed with multiple sclerosis.
Quality of life and employment in persons with multiple sclerosis.
Statins and Neuroprotection: Basic Pharmacology Needed.
Non-local spatial regularization of MRI T2 relaxation images for myelin water quantification.
Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.
Phospholipase D1 mediates lymphocyte adhesion and migration in experimental autoimmune encephalomyelitis.
Immunomodulatory effects of 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors, potential therapy for relapsing remitting multiple sclerosis.
Current standards of treatment in ms and the role of oral agents.
Massive exacerbation of multiple sclerosis after withdrawal and early restart of treatment with natalizumab.
Multifocal Acquired Demyelinating Sensory and Motor Neuropathy: Unexpected Diagnosis After Ultrasound Imaging for a Humeral Fracture.
TREM2 regulates microglial cell activation in response to demyelination in vivo.
Patient-identified factors that influence spasticity in people with stroke and multiple sclerosis receiving botulinum toxin injection treatments.
Autonomic dysfunction in clinically isolated syndrome suggestive of multiple sclerosis.
Carbon Monoxide and the Brain : Time to Rethink the Dogma.
The Usefulness of Gadolinium-Enhanced Images on a Follow-up Magnetic Resonance Image in Suspected Multiple Sclerosis.
Mean Contact Quotient Using Electroglottography in Patients With Multiple Sclerosis.
Long-term outcome of paediatric-onset multiple sclerosis: a population-based study.
Cell-Based Reporter Gene Assay for Therapy-Induced Neutralizing Antibodies to Interferon-Beta in Multiple Sclerosis.
Evaluating risks, costs, and benefits of new and emerging therapies to optimize outcomes in multiple sclerosis.
Pages
« first
‹ previous
…
392
393
394
395
396
397
398
399
400
…
next ›
last »